Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

DMD Treatment Gets Orphan Drug, Rare Pediatric Disease Designations

By Aug 17, 2018

DMD is predominately caused by out-of-frame deletions in the dystrophin gene, which results in absent or defective dystrophin protein, leading to progressive and irreversible muscle function loss.

First Generic Version of EpiPen Gets FDA Approval

By Aug 16, 2018

Unlike other generic approvals, epinephrine auto-injectors are considered "combination products" because they consist of both a drug and a device, making the approval process more challenging.

FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women

By Aug 16, 2018

The FDA has set a Prescription Drug User Fee Act target date of April 1, 2019.

Biologic Therapy Selection for Severe Asthma: Factors to Consider

By Aug 15, 2018

The authors write that once severe asthma is diagnosed, clinicians should determine asthma endotype (Type2-high or Type2-low) to help choose the best therapy for the patient.

FDA: Improper Use of Rupture of Membranes Tests Linked to Fetal Deaths

By Aug 09, 2018

ROM tests are used to aid in diagnosing ruptured membranes in pregnant women through analysis of vaginal secretions.

More Articles by Diana Ernst, RPh